Breakout Ventures - aVenture Asset Manager Research
Location
San Francisco, CA, US
Founded
2016
Breakout Ventures is an early-stage investment fund focused on supporting bold, science-based startups. The firm typically invests in Seed, Series A, and Series B rounds, with a strong emphasis on companies that leverage scientific innovation to drive their business models. Breakout Ventures seeks to back visionary scientist entrepreneurs who are pioneering new technologies and solutions across various sectors.
Notable portfolio companies include A-Alpha Bio, Canaery, Checkerspot, Cytovale, EnPlusOne Biosciences, Immusoft, Modern Meadow, Parallel Bio, Parthenon Therapeutics, Phantom Neuro, Phylagen, ShiraTronics, Surf Bio, Twelve, Twelve Benefit, and Zymochem. The firm prides itself on its investment philosophy of nurturing groundbreaking scientific ventures and offers unique value-add services to its portfolio companies, such as strategic guidance and access to a robust network of industry experts and partners.
Breakout Ventures - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
